Ovol2 induces mesenchymal–epithelial transition via targeting ZEB1 in osteosarcoma
暂无分享,去创建一个
Hong Wu | Yulong Wei | Hong Wu | L. Duan | Jijun Liu | Qi Wu | Yonggui Wang | Lijun Duan | Qiang Zhang | Yonggang Wu | Qiang Zhang | Yulong Wei | Yonggang Wu | Jijun Liu | Qi Wu | Yonggui Wang
[1] Eshel Ben-Jacob,et al. Coupling the modules of EMT and stemness: A tunable ‘stemness window’ model , 2015, Oncotarget.
[2] James E. Verdone,et al. The Presence of Androgen Receptor Elements Regulates ZEB1 Expression in the Absence of Androgen Receptor , 2015, Journal of cellular biochemistry.
[3] C. Chen,et al. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. , 2016, Gastroenterology.
[4] C. Ghigna,et al. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression , 2017, Molecular Cancer.
[5] Hua Guo,et al. Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma , 2016, OncoTargets and therapy.
[6] Y. Iwakura,et al. Ovol2/Movo, a homologue of Drosophila ovo, is required for angiogenesis, heart formation and placental development in mice , 2007, Genes to cells : devoted to molecular & cellular mechanisms.
[7] Zhengming Zhou,et al. Snail-1 regulates VDR signaling and inhibits 1,25(OH)-D₃ action in osteosarcoma. , 2011, European journal of pharmacology.
[8] Junjiang Fu,et al. Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer , 2014, Tumor Biology.
[9] M. Tomic-Canic,et al. Epithelial-mesenchymal transition in tissue repair and fibrosis , 2016, Cell and Tissue Research.
[10] T. He,et al. The Current and Future Therapies for Human Osteosarcoma. , 2013, Current cancer therapy reviews.
[11] T. Haneji,et al. Negative regulation of TIMP1 is mediated by transcription factor TWIST1. , 2009, International journal of oncology.
[12] Chibo Liu,et al. Interplay Between Long Noncoding RNA ZEB1‐AS1 and miR‐200s Regulates Osteosarcoma Cell Proliferation and Migration , 2017, Journal of cellular biochemistry.
[13] Christopher G. Hill,et al. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. , 2011, Gynecologic oncology.
[14] James J. Morrow,et al. Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies. , 2015, Critical reviews in oncogenesis.
[15] F. Kruyt,et al. EMT‐ and MET‐related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities , 2017, Molecular oncology.
[16] Yong Zhou,et al. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST , 2014, Journal of experimental & clinical cancer research : CR.
[17] Xue Leng,et al. Zinc finger E‐box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial‐to‐mesenchymal transition , 2012, Cancer science.
[18] N. Goshima,et al. OVOL2 Maintains the Transcriptional Program of Human Corneal Epithelium by Suppressing Epithelial-to-Mesenchymal Transition. , 2016, Cell reports.
[19] Bogi Andersen,et al. Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor. , 2014, Developmental cell.
[20] Huiguang Yang,et al. Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma , 2012, Journal of surgical oncology.
[21] Di Wu,et al. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis , 2017, Oncotarget.
[22] Natalie K. Wolf,et al. A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis , 2015, Nature Genetics.
[23] Li Ma,et al. ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance , 2015, Cell cycle.
[24] M. Hu,et al. The mouse Ovol2 gene is required for cranial neural tube development. , 2006, Developmental biology.
[25] J. Schulzke,et al. A Grainyhead-Like 2/Ovo-Like 2 Pathway Regulates Renal Epithelial Barrier Function and Lumen Expansion. , 2015, Journal of the American Society of Nephrology : JASN.
[26] Zhong Li,et al. Ovol2 gene inhibits the Epithelial-to-Mesenchymal Transition in lung adenocarcinoma by transcriptionally repressing Twist1. , 2017, Gene.
[27] Imelda M. McGonnell,et al. Snail2 promotes osteosarcoma cell motility through remodelling of the actin cytoskeleton and regulates tumor development , 2013, Cancer letters.
[28] H. Uchi,et al. Potential role of the OVOL1–OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma , 2017, Modern Pathology.
[29] Qing Nie,et al. Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells. , 2014, Developmental cell.
[30] Dongxu Zhao,et al. MicroRNA-187 exerts tumor-suppressing functions in osteosarcoma by targeting ZEB2. , 2016, American journal of cancer research.
[31] Y. Oda,et al. Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma. , 2016, The American journal of pathology.
[32] Eshel Ben-Jacob,et al. Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis , 2015, Front. Oncol..